SEC Form 4/A · accession 0000899243-18-003707
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Mette Kirstine Agger
Director · 10% Owner
Period of report
Nov 21, 2017
Accepted (ET)
Feb 13, 2018 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 21, 2017 | P | 654,762 | $14.00 | A | 3,183,986 | I | By: Lundbeckfond Invest A/S |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 21, 2017, the Reporting Person filed a Form 4 which inadvertently excluded the purchase of shares in the Initial Public Offering of the Issuer by Lundbeckfond Invest A/S ("LIAS") of 654,762 shares of Common Stock (the "Purchase"). This amendment corrects the exclusion of the purchase by LIAS. The Purchase was reported on a Form 4 filed by LIAS with the U.S. Securities and Exchange Commission on November 21, 2017.
- F2These shares are directly held by LIAS. The Reporting Person is the Managing Partner of LIAS. The reporting person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.